Friedrich-Alexander University Erlangen-Nuremberg and University Hospital Erlangen, Erlangen, Germany.
Arthritis Rheumatol. 2022 May;74(5):871-881. doi: 10.1002/art.42033. Epub 2022 Mar 29.
Mitochondrial transcription factor A (TFAM) controls the transcription of core proteins required for mitochondrial homeostasis. This study was undertaken to investigate changes in TFAM expression in systemic sclerosis (SSc), to analyze mitochondrial function, and to evaluate the consequences for fibroblast activation.
TFAM expression was analyzed by immunofluorescence and Western blotting. The effects of TFAM knockout were investigated in cultured fibroblasts and in murine models of bleomycin-induced skin fibrosis, bleomycin-induced lung fibrosis, and skin fibrosis induced by overexpression of constitutively active transforming growth factor β type I receptor (TGFβRΙ).
TFAM expression was down-regulated in fibroblasts in SSc skin and in cultured SSc fibroblasts. The down-regulation of TFAM was associated with decreased mitochondrial number and accumulation of damaged mitochondria with release of mitochondrial DNA (mtDNA), accumulation of deletions in mtDNA, metabolic alterations with impaired oxidative phosphorylation, and release of the mitokine GDF15. Normal fibroblasts subjected to long-term, but not acute, exposure to TGFβ mimicked SSc fibroblasts, with down-regulation of TFAM and accumulation of mitochondrial damage. Down-regulation of TFAM promoted fibroblast activation with up-regulation of fibrosis-relevant Gene Ontology terms in RNA-Seq, partially in a reactive oxygen species-dependent manner. Mice with fibroblast-specific knockout of Tfam were prone to fibrotic tissue remodeling, with fibrotic responses even to NaCl instillation and enhanced sensitivity to bleomycin injection and overexpression of constitutively active TGFβRI. TFAM knockout fostered Smad3 signaling to promote fibroblast activation.
Alterations in the key mitochondrial transcription factor TFAM in response to prolonged activation of TGFβ and associated mitochondrial damage induce transcriptional programs that promote fibroblast-to-myofibroblast transition and drive tissue fibrosis.
线粒体转录因子 A(TFAM)控制线粒体稳态所需核心蛋白的转录。本研究旨在研究系统性硬化症(SSc)中 TFAM 表达的变化,分析线粒体功能,并评估其对成纤维细胞激活的影响。
通过免疫荧光和 Western blot 分析 TFAM 表达。在培养的成纤维细胞中和在博来霉素诱导的皮肤纤维化、博来霉素诱导的肺纤维化以及过表达组成性激活的转化生长因子β型 I 受体(TGFβRΙ)诱导的皮肤纤维化的小鼠模型中研究 TFAM 敲除的影响。
SSc 皮肤和成纤维细胞中的 TFAM 表达下调。TFAM 的下调与线粒体数量减少和受损线粒体堆积有关,导致线粒体 DNA(mtDNA)释放、mtDNA 缺失积累、代谢改变伴氧化磷酸化受损以及mitokine GDF15 的释放。正常成纤维细胞长期(而非急性)暴露于 TGFβ 可模拟 SSc 成纤维细胞,TFAM 下调和线粒体损伤堆积。TFAM 的下调促进成纤维细胞激活,RNA-Seq 中纤维化相关基因本体论术语上调,部分依赖于活性氧物质。成纤维细胞特异性敲除 Tfam 的小鼠易发生纤维化组织重塑,即使在 NaCl 滴注和增强对博来霉素注射和过表达组成性激活 TGFβRI 的敏感性时也会发生纤维化反应。Tfam 敲除促进 Smad3 信号转导以促进成纤维细胞激活。
TGFβ 持续激活和相关线粒体损伤导致关键线粒体转录因子 TFAM 的改变,诱导促进成纤维细胞向肌成纤维细胞转化和驱动组织纤维化的转录程序。